-
When Cancer Rings Twice
One out of every six people diagnosed with cancer this year will be facing it for, at least, the second time.
by Melissa Weber
-
Yesterday & Today
The Amazing RideSally Ride's life was cut short by pancreatic cancer. But as the first American woman in space, she still inspires girls to pursue careers in science–and reach for the stars.
by Alexandra Goho
-
Changing the Face of Clinical Trials
Efforts are under way to increase African-American enrollment in cancer clinical trials.
by Leslie Harris O'Hanlon
-
Forever Young
In images of four breast cancer survivors navigating the medical system, photographer David Jay captures portraits of emotional strength, economic struggle and hope.
by Cynthia Ryan
-
In the Moment- Spring 2013
Valentina Londono, Beth Foster, Michael Knowlton, Beverly Brehl.
-
First Person
Keeping Sight of HopeA survivor keeps an eye on what's ahead after a rare cancer diagnosis.
by Sue Russell
-
Survivor Profile
Let’s Talk: Lee MillerDrawing on her own struggle with the emotional pain of a cancer diagnosis and treatment, Lee Miller empowers other patients to effectively communicate with their doctors.
by Jenny Song
-
Yesterday & Today
The Sex Machine vs. Prostate CancerEven cancer couldn't slow down James Brown.
by Jocelyn Selim
-
Survivor Profile
Patients’ Rights PowerhouseMyra Christopher wages a personal battle with a rare cancer while continuing to passionately advocate for patients.
by Charlotte Huff
-
In the Moment- Winter 2012/2013
Julia Wiley, Tony Handler, Michael B. Lawing, Lori Petitti
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff